General Information
Version
4
Revision date
2025-12-21
Product name
Carboplatin
Product Synonyms
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum; Carboplatin
CAS No.
41575-94-4
Emergency telephone
1-800-234-7437, 001-800-227-6701, +32 14 57 52 11, 001-201-796-7100, +32 14 57 52 99, 001-800-424-9300, 001-703-527-3887
Icons in SDS
Company Information
company name
Fisher Scientific
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H332
Hazard statements
Code
Statements
H332
Harmful if inhaled
Section 2
SECTION 2: Hazards identification
WHMIS 2015 Classification
Signal word
Danger Hazard Statements Harmful if swallowed, in contact with skin or if inhaled May cause an allergic skin reaction May cause allergy or asthma symptoms or breathing difficulties if inhaled May cause genetic defects May cause cancer May damage fertility or the unborn child Harmful if inhaled
Prevention
Obtain special instructions before use Do not handle until all safety precautions have been read and understood Wear protective gloves/protective clothing/eye protection/face protection Avoid breathing dust/fume/gas/mist/vapors/spray Wash face, hands and any exposed skin thoroughly after handling Do not eat, drink or smoke when using this product Use only outdoors or in a well-ventilated area Contaminated work clothing should not be allowed out of the workplace Wear respiratory protection
Response
IF exposed or concerned: Get medical advice/attention IF ON SKIN: Wash with plenty of soap and water IF INHALED: Remove person to fresh air and keep comfortable for breathing Call a POISON CENTER/ doctor if you feel unwell Rinse mouth If experiencing respiratory symptoms: Call a POISON CENTER/doctor Take off contaminated clothing and wash it before reuse
Storage
Store locked up
Disposal
Dispose of contents/container to an approved waste disposal plant
2.1 Classification of the substance or mixture
WHMIS 2015 Classification This product is hazardous in accordance with the Canada Hazardous Products Act (HPA) and Hazardous Products Regulation (HPR), as amended (SOR/2022-272) Acute oral toxicity Category 4 Acute dermal toxicity Category 4 Acute Inhalation Toxicity Category 4 Respiratory Sensitization Category 1 Skin Sensitization Category 1 Germ Cell Mutagenicity Category 1A Carcinogenicity Category 1B Reproductive Toxicity